Assurex Health, Inc., headquartered in the United States, is a pioneering company in the field of personalised medicine, specialising in pharmacogenomics. Founded in 2006, Assurex Health has made significant strides in transforming how healthcare providers approach medication management, particularly in mental health and pain management. The company’s flagship product, GeneSight, is a genetic test that helps clinicians tailor medication choices based on a patient’s unique genetic profile, enhancing treatment efficacy and minimising adverse effects. Assurex Health has established a strong market position, recognised for its innovative approach to improving patient outcomes through precision medicine. With a commitment to advancing personalised healthcare, Assurex Health continues to lead the way in the pharmacogenomics industry, serving healthcare providers across the US and beyond.
How does Assurex Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Assurex Health, Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Assurex Health, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Assurex Health may inherit climate-related data and commitments from its parent organisation; however, no specific details regarding such cascaded information have been provided. This lack of data suggests that Assurex Health has yet to establish measurable climate commitments or reduction initiatives within the industry context. In summary, without available emissions data or defined climate strategies, Assurex Health's current environmental impact and commitments remain unclear.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 1,414,000 |
| Scope 2 | 1,540,000 |
| Scope 3 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Assurex Health, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.